-
Loading metrics
The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
- Rebecca C. Coll,
- Luke A. J. O'Neill
x
- Published: December 22, 2011
- https://doi.org/10.1371/journal.pone.0029539
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Loading metrics